Grumiller, Jan; Grohs, Hannes; Reiner, Christian - 2021
The COVID-19 pandemic has exposed the fragility of medical product and pharmaceutical global value chains (GVCs …, there is currently no consensus on which policies are required to ensure supply security for 'critical' or 'essential …) penicillin (antibiotic), (b) paracetamol (analgesic), and (c) heparin (anticoagulant) for pharmaceuticals. The effects of COVID …